Ranjit Kapadia, Senior VP - Pharma - Centrum Broking says the firms numbers are very good on the top-line and margins front. Money Control, 1 month ago
Past issues, heavy attrition at the root of Ranbaxys problems: Ranjit Kapadia, Centrum Broking - Economic Times, 1 month ago
2 images for "ranjit kapadia"
H Below is the edited transcript of Ranjit Kapadia and Sarabjit Kaur Nangras interview with CNBC-TV18s Ekta Batra and Sumaira Abidi. For the complete interview watch the video. Ekta: Is there any exceptional which has come out with the Dr Reddys ...Moneycontrol.com, 3 weeks ago
"Wockhardt has been languishing for some time now, whereas in case of Aurobindo, there is a steady flow of news on the launch of their generic products." In a chat with ET Now, Ranjit Kapadia, Sr VP-Pharma, Centrum Broking Limited, shares his views on some ...Economic Times, 2 months ago
In an online chat with readers between 4 pm and 5 pm, Dr Ranjit Goswami, dean, IMT Nagpur answered questions on the various MBA programmes available in the country, the eligibility criteria for admission and offer advice on how to pick the right course and institute. Do you want to pursue an MBA from a good institute in India? It is an established fact that an MBA from a reputed institute is an add on to your CV and your career. If you haven't decided on the institute, perhaps, you can consider ...Rediff.com, 2 months ago
But Dr Reddy's, a major player in the region, can expect some overhang on its stock till the issue is resolved fully, say analysts Ujjval Jauhari March 4, 2014 Last Updated at 22:09 IST As the Ukraine crisis brought jitters to bourses worldwide, the ...Business Standard India, 4 days ago Russia-Ukraine Crisis: Limited bearing on Indian Pharma Industry Business Standard India, 5 days ago
MUMBAI : Pharmaceutical major AstraZeneca Pharmaceuticals AB's plans to delist its Indian subsidiary AstraZeneca Pharma India may not be an easy task considering that high expectations have derailed similar attempts by the Anglo-Swedish drug maker ...The Freepress Journal, 5 days ago AstraZeneca mulls delisting, stock jumps 20% Hindu Business Line, 5 days ago Sun Pharma profit rises 74% to Rs 1,531 cr in Q3 Financial Chronicle, 3 weeks ago On the road to recovery Financial Chronicle, 3 weeks ago
Indian drugmakers are finally sitting up to take note of how to make medicines the healthy way. They have been forced to tweak age-old practices by cleaning up hygiene issues at their plants. And its not because the drug controller at home insisted that they ...The Financial Chronicle, 1 week ago
3:40 p.m. Sensex gains for third day, ends 41 points higher at 20,852; Nifty closes at 6,200. The IT index was the biggest gainer among the sectoral indices. Wipro rose 3.2 per cent, Infosys gained 0.9 per cent while TCS rose 0.5 per cent. 3:32 ...NDTV Profit, 1 week ago
10.50 a.m. Ambuja Cements stays at the top of the Nifty benchmark. Buying has picked up in the counter on hopes of a price hike. ( Track stock ) 10.42 a.m. Market update: Nifty slips below 6,200 as banking stocks pare gains. ( Track stocks ) ...NDTV Profit, 1 week ago Stock market live: Nifty soars above 6200; banks gain NDTV Profit, 1 week ago Stock market live: Nifty inches back above 6200, IT stocks lead NDTV Profit, 1 week ago Stock market live: Sensex flat amid choppy trade; IT cement, stocks gain NDTV Profit, 1 week ago
Shares of Pfizer Ltd surged as much as 18.1 percent to mark their highest intraday level since December 9, after the company said a unit of its parent Pfizer Inc will buy a near 61 percent stake from two other units after an internal restructuring. ...NDTV Profit, 1 week ago Pfizer surges on parent's restructuring Yahoo! Finance, 1 week ago Pfizer surges 18% on parent's restructuring Moneycontrol.com, 1 week ago
More from: , Reuters India...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!